Estimating the Numbers of Malaria Infections in Blood Samples Using High-Resolution Genotyping Data

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ross, Amanda ^a,b   Koepfli, Cristian ^a,b,c   Li, Xiaohong ^d   Schoepflin, Sonja ^a,b,g   Siba, Peter ^e   Mueller, Ivo ^c,e,f   Felger, Ingrid ^a,b   Smith, Thomas ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d BG Medicine Inc   (United States)

^e PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^g Roche Pharma Schweiz AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; INFECTION RATE; INTERMETHOD COMPARISON; MALARIA; MATHEMATICAL COMPUTING; MIXED INFECTION; OPTICAL RESOLUTION; PERFORMANCE MEASUREMENT SYSTEM; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; SIMULATION;

ALGORITHMS; ALLELES; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; GENE FREQUENCY; GENOTYPE; HUMANS; INFECTIOUS DISEASE MEDICINE; MALARIA, FALCIPARUM; MALARIA, VIVAX; MODELS, STATISTICAL; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84865607636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042496     Document Type: Article

References (28)

1. Carter R, Macgregor I, (1973) Enzyme variation in Plasmodium falciparum in The Gambia. Trans Roy Soc Trop Med Hyg 67: 830-837.
2. Hill W, Babiker H, (1995) Estimation of numbers of malaria clones in blood samples. Proc R Soc Lond B 262: 249-257.
3. Li X, Foulkes A, Yucel R, Rich S, (2007) An expectation maximization approach to estimate malaria haplotype frequencies in multiply infected children. Stat Appl Genet Mol Biol 6: 33.
4. Li X, Thomas B, Rich S, Ecker D, Tumwine J, et al. (2009) Estimating and testing haplotype-trait association in non-diploid populations. Appl Statist 58: 663-678.
5. Lunn D, Thomas A, Best N, Spiegelhalter D, (2000) WinBUGS- a Bayseian modelling framework: concepts, structure, and extensibility. Stat Comput 10: 325-337.
6. R Development Core Team (2010) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. URL http://www.R-project.org/ Accessed: 2011 Jan 7.
7. Dempster A, Laird N, Rubin D, (1977) Maximum likelihood from incomplete data via the EM algorithm. J Roy Statist Soc B 39.
8. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, et al. (2010) Differential patterns of infection and disease with P falciparum and P vivax in young Papua New Guinean children. PLoS ONE 5: e9047.
9. Schoepflin S, Valsangiacomo F, Lin E, Kiniboro B, Mueller I, et al. (2009) Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar J 8: 250.
10. Koepfli C, Schoepflin S, Bretscher M, Lin E, Kiniboro B, et al. (2011) How much remains unde-tected? Probability of molecular detection of human Plasmodia in the field. PLoS ONE 6: e19010.
11. Koepfli C, Ross A, Kiniboro B, Smith T, Zimmerman P, et al. (2011) Multiplicity and diversity in a highly endemic region in Papua New Guinea. PLoS NTD 5: e1424.
12. McNamara D, Kasehagen L, Grimberg B, Cole-Tobian J, Collins W, et al. (2006) Diagnosing infec-tion levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg 74: 413-21.
13. WHO (2008) Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, The Netherlands. Geneva.
14. Hastings I, Smith T, (2008) MalHaploFreq: a computer programme for estimating malaria haplo-type frequencies from blood samples. Malar J 7: 130.
15. Antao T, Hastings I, (2011) Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria. Proc Biol Sci 278 (1712):: 1705-12.
16. Juliano J, Gadalla N, Sutherland C, Meshnick S, (2010) The perils of PCR: can we accurately 'correct' antimalarial trials? Trends Parasitol 26: 119-124.
17. Juliano J, Taylor S, Meshnick S, (2009) Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? J Inf Dis 200: 5-7.
18. Faernert A, Arez A, Babiker H, Beck H, Benito A, et al. (2001) Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans Roy Soc Trop Med Hyg 95: 225-32.
19. Bretscher M, Valsangiacomo F, Owusu-Agyei S, Penny M, Felger I, et al. (2010) Detectibility of Plasmodium falciparum clones. Malar J 9: 234.
20. Bruce M, Galinski M, Barnwell J, Donnelly C, Walmsley M, et al. (2000) Genetic diversity and dynamics of Plasmodium falciparum and P vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitol 121: 257-72.
21. Hastings I, Nsanzabana C, Smith T, (2010) A comparison of methods to detect and quantify the markers of antimalarial drug resistance. Am J Trop Med Hyg 83: 489-93.
22. Bejon P, Turner L, Lavstsen T, Cham G, Olotu A, et al. (2011) Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites. PLoS ONE 6: e21711.
23. Gatton M, Cheng Q, (2008) Can estimates of antimalarial efficacy from field studies be improved? Trends Parasitol 24: 68-73.
24. Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal P, Dorsey G, (2007) Impact of transmis-sion intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Antimicrobial Agent Chemother 51: 3096-3103.
25. Gupta V, Dorsey G, Hubbard A, Rosenthal P, Greenhouse B, (2010) Gel versus capillary elec-trophoresis genotyping for categorizing treatment outcomes in two antimalarial trials in Uganda. Malar J 9: 19.
26. Kwiek J, Alker A, Wenink E, Chaponda M, Kalilani L, et al. (2007) Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections. Antimicrob Agent Chemother 51: 521-7.
27. Slater M, Kiggundu M, Dokomajilar C, Kamya M, Bakyaita N, et al. (2005) Distinguishing recrudescence from new infections in antimalarial clinical tials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am J Trop Med Hyg 73: 256-262.
28. Stepniewska K, White N, (2006) Some considerations in the design and interpretation of antimalar-ial drug trials in uncomplicated falciparum malaria. Malar J 5: 127.